LeMaitre Vascular, Inc. - stock earnings
LMAT Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| April 30, 2024 BeforeMarket | 50.8 million | 51.5 million | 51.8 million |
LMAT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 8.5 million USD | 48.9 million USD |
| 2023Q3 | 7.5 million USD | 47.4 million USD |
| 2023Q2 | 8.1 million USD | 50.1 million USD |
| 2023Q1 | 6.0 million USD | 47.1 million USD |
| 2022Q4 | 5.6 million USD | 41.0 million USD |
| 2022Q3 | 5.5 million USD | 39.0 million USD |
| 2022Q2 | 3.5 million USD | 42.1 million USD |
| 2022Q1 | 6.0 million USD | 39.6 million USD |
| 2021Q4 | 6.2 million USD | 39.5 million USD |
| 2021Q3 | 6.5 million USD | 38.4 million USD |
| 2021Q2 | 8.3 million USD | 40.7 million USD |
| 2021Q1 | 5.9 million USD | 35.9 million USD |
| 2020Q4 | 7.0 million USD | 37.5 million USD |
| 2020Q3 | 7.5 million USD | 36.4 million USD |
| 2020Q2 | 3.5 million USD | 24.9 million USD |
| 2020Q1 | 3.2 million USD | 30.6 million USD |
| 2019Q4 | 4.6 million USD | 30.2 million USD |
| 2019Q3 | 5.2 million USD | 29.1 million USD |
| 2019Q2 | 4.6 million USD | 29.5 million USD |
| 2019Q1 | 3.5 million USD | 28.5 million USD |
| 2018Q4 | 6.0 million USD | 28.4 million USD |
| 2018Q3 | 4.3 million USD | 24.2 million USD |
| 2018Q2 | 8.8 million USD | 27.0 million USD |
| 2018Q1 | 3.9 million USD | 26.0 million USD |
| 2017Q4 | 4.3 million USD | 26.2 million USD |
| 2017Q3 | 5.0 million USD | 24.8 million USD |
| 2017Q2 | 4.6 million USD | 25.8 million USD |
| 2017Q1 | 3.2 million USD | 24.1 million USD |
| 2016Q4 | 2.6 million USD | 23.3 million USD |
| 2016Q3 | 3.2 million USD | 23.2 million USD |
| 2016Q2 | 2.6 million USD | 22.4 million USD |
| 2016Q1 | 2.2 million USD | 20.3 million USD |
| 2015Q4 | 2.5 million USD | 20.5 million USD |
| 2015Q3 | 2.1 million USD | 19.0 million USD |
| 2015Q2 | 1.8 million USD | 19.9 million USD |
| 2015Q1 | 1.4 million USD | 18.9 million USD |
| 2014Q4 | 1.9 million USD | 18.7 million USD |
| 2014Q3 | 934000 USD | 17.5 million USD |
| 2014Q2 | 1.3 million USD | 18.2 million USD |
| 2014Q1 | -207000 USD | 16.8 million USD |
| 2013Q4 | 746000 USD | 17.9 million USD |
| 2013Q3 | 781000 USD | 15.3 million USD |
| 2013Q2 | 889000 USD | 16.0 million USD |
| 2013Q1 | 846000 USD | 15.4 million USD |
| 2012Q4 | 698000 USD | 14.8 million USD |
| 2012Q3 | 663000 USD | 13.6 million USD |
| 2012Q2 | 824000 USD | 14.4 million USD |
| 2012Q1 | 386000 USD | 13.9 million USD |
| 2011Q4 | 346000 USD | 13.4 million USD |
| 2011Q3 | 1.2 million USD | 14.6 million USD |
| 2011Q2 | 519000 USD | 15.1 million USD |
| 2011Q1 | 64000 USD | 14.6 million USD |
| 2010Q4 | 2.0 million USD | 14.4 million USD |
| 2010Q3 | 1.5 million USD | 13.7 million USD |
| 2010Q2 | 1.5 million USD | 14.2 million USD |
| 2010Q1 | 1.0 million USD | 13.8 million USD |
| 2009Q4 | 1.3 million USD | 13.6 million USD |
| 2009Q3 | 1.3 million USD | 13.3 million USD |
| 2009Q2 | 925000 USD | 12.6 million USD |
| 2009Q1 | -1.9 million USD | 11.3 million USD |
| 2008Q4 | 312000 USD | 12.1 million USD |
| 2008Q3 | -136000 USD | 12.0 million USD |
| 2008Q2 | -926000 USD | 12.7 million USD |
| 2008Q1 | -2.6 million USD | 11.8 million USD |
| 2007Q4 | -1.2 million USD | 11.1 million USD |
| 2007Q3 | -1.4 million USD | 10.1 million USD |
| 2007Q2 | 227000 USD | 10.3 million USD |
| 2007Q1 | -629000 USD | 9.9 million USD |
| 2006Q4 | -674000 USD | 8.8 million USD |
| 2006Q3 | 222000 USD | 8.5 million USD |
| 2006Q2 | -1.1 million USD | 8.8 million USD |
| 2006Q1 | 370000 USD | 8.6 million USD |
| 2005Q4 | 41000 USD | 7.9 million USD |
| 2005Q3 | -42000 USD | 7.8 million USD |
| 2005Q2 | 5000 USD | 7.5 million USD |
| 2005Q1 | 51000 USD | 7.5 million USD |
| 2004Q4 | 231000 USD | 6.5 million USD |
| 2004Q3 | 232000 USD | 6.5 million USD |
| 2004Q2 | 232000 USD | 6.5 million USD |
| 2004Q1 | 232000 USD | 6.5 million USD |
LMAT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 30.1 million USD | 193.5 million USD |
| 2022 | 20.6 million USD | 161.7 million USD |
| 2021 | 26.9 million USD | 154.4 million USD |
| 2020 | 21.2 million USD | 129.4 million USD |
| 2019 | 17.9 million USD | 117.2 million USD |
| 2018 | 22.9 million USD | 105.6 million USD |
| 2017 | 17.2 million USD | 100.9 million USD |
| 2016 | 10.6 million USD | 89.2 million USD |
| 2015 | 7.8 million USD | 78.4 million USD |
| 2014 | 3.9 million USD | 71.1 million USD |
| 2013 | 3.2 million USD | 64.5 million USD |
| 2012 | 2.6 million USD | 56.7 million USD |
| 2011 | 2.1 million USD | 57.7 million USD |
| 2010 | 6.0 million USD | 56.1 million USD |
| 2009 | 1.6 million USD | 50.9 million USD |
| 2008 | -3.3 million USD | 48.7 million USD |
| 2007 | -2.9 million USD | 41.4 million USD |
| 2006 | -1.2 million USD | 34.6 million USD |
| 2005 | 55000 USD | 30.7 million USD |
| 2004 | 927000 USD | 26.2 million USD |
| 2003 | -222000 USD | 20.7 million USD |
| 2002 | 483000 USD | 17.4 million USD |
| 2001 | -605000 USD | 12.6 million USD |
LMAT
List: Contenders
Price: $62.62
Dividend Yield: 0.01%
Forward Dividend Yield: 1.02%
Payout Ratio: 52.46%
Dividend Per Share: 0.64 USD
Earnings Per Share: 1.34 USD
P/E Ratio: 50.39
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 56800
Ebitda: 6.1 millionMarket Capitalization: 1.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 12.12%
DGR5: 14.37%
DGR10: 14.46%